Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.
- DOI
- 10.1111/nan.70101
- Published
- 2026 Oct
- Container
- Neuropathology and applied neurobiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/nan.70101,
title = {Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.},
author = {Ricci AA and Nozzoli F and Biale A and Tampieri C and Verdun di Cantogno L and Garbossa D and Levis M and Rudà R and Bonaudo C and Della Puppa A and Livi L and Desideri I and Cassoni P and Bertero L},
year = {2026},
journal = {Neuropathology and applied neurobiology},
doi = {10.1111/nan.70101},
url = {https://doi.org/10.1111/nan.70101}
}RIS
TY - JOUR TI - Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival. AU - Ricci AA AU - Nozzoli F AU - Biale A AU - Tampieri C AU - Verdun di Cantogno L AU - Garbossa D AU - Levis M AU - Rudà R AU - Bonaudo C AU - Della Puppa A AU - Livi L AU - Desideri I AU - Cassoni P AU - Bertero L PY - 2026 JO - Neuropathology and applied neurobiology DO - 10.1111/nan.70101 UR - https://doi.org/10.1111/nan.70101 ER -
APA
AA, R., F, N., A, B., C, T., L, V. D. C., D, G., M, L., R, R., C, B., A, D. P., L, L., I, D., P, C., & L, B. (2026). Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.. Neuropathology and applied neurobiology. https://doi.org/10.1111/nan.70101
Source records
- pubmed · retrieved 2026-09-25T17:44:20.210Z